Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NICHE: Hydralazine and Isosorbide Dinitrate in Cardiorenal Syndrome
NCT02343393Phase 3Unknown
- Sponsor
- National University Hospital
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of hydralazine and isosorbide dinitrate in cardiorenal syndrome (CRS) (2 arms), sponsored by National University Hospital. Primary endpoint: 6 Minute Walk Test at 24 weeks. Status: unknown.
02
Drugs
hydralazineisosorbide dinitrate
03
Conditions
cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT02343393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343393.